The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predicting hyperglycemia among patients receiving alpelisib plus fulvestrant for metastatic breast cancer.
 
Xuan Ge
No Relationships to Disclose
 
Carolyn E. Behrendt
No Relationships to Disclose
 
Susan Elaine Yost
No Relationships to Disclose
 
Niki Patel
Honoraria - OncLive Clinical Congress Consultants
 
Raynald Samoa
No Relationships to Disclose
 
Daphne B. Stewart
No Relationships to Disclose
 
Mina S. Sedrak
Research Funding - Lilly (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst)
 
Sayeh Moazami Lavasani
Honoraria - Puma Biotechnology; Seagen
Consulting or Advisory Role - Puma Biotechnology
Speakers' Bureau - Puma Biotechnology; Seagen
 
James Ross Waisman
No Relationships to Disclose
 
Yuan Yuan
Consulting or Advisory Role - BCI Pharma; Diiachi; Eisai; Genentech; Guardant Health; Immunomedics; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Lilly; Eisai; Genentech
Research Funding - Genentech; Imugene; Merck; Novartis; Pfizer
Expert Testimony - Novartis
 
Joanne E. Mortimer
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Pfizer; Puma Biotechnology